Shares of Alliance Pharma plc (LON:APH – Get Free Report) crossed below its two hundred day moving average during trading on Monday . The stock has a two hundred day moving average of GBX 39.04 ($0.49) and traded as low as GBX 37.10 ($0.46). Alliance Pharma shares last traded at GBX 37.25 ($0.46), with a volume of 441,309 shares.
Wall Street Analysts Forecast Growth
Separately, Royal Bank of Canada cut their target price on shares of Alliance Pharma from GBX 65 ($0.81) to GBX 60 ($0.75) and set an “outperform” rating for the company in a research report on Wednesday, January 31st.
Get Our Latest Research Report on APH
Alliance Pharma Stock Up 3.1 %
Alliance Pharma Company Profile
Alliance Pharma plc operates as a pharmaceutical company in Europe, the Middle East, Africa, the Asia Pacific, China, and the Americas. The company acquires, markets, and distributes consumer healthcare and prescription medicine products. The company also offers medicines, medical devices, food supplements, and cosmetics.
Recommended Stories
- Five stocks we like better than Alliance Pharma
- Unveiling The Power Of VWAP: A Key Indicator For Traders
- The Charles Schwab Company Can Hit New Highs
- Why Are Stock Sectors Important to Successful Investing?
- Costco vs. Walmart: Revenue Comparison of Two Retail Giants
- CD Calculator: Certificate of Deposit Calculator
- 3 Energy Plays for Cash Flow: Buy 1 or Buy Them All
Receive News & Ratings for Alliance Pharma Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Alliance Pharma and related companies with MarketBeat.com's FREE daily email newsletter.